Home › NDC Lookup › RxCUI directory › RxCUI 1998483

Doxycycline hyclate 200 MG Injection — RxCUI 1998483

RxNorm drug concept · Semantic clinical drug
RxCUI 1998483 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1998483
Official nameDoxycycline hyclate 200 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)631 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Doxycycline Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The IV form is used when you can't take medications by mouth — for example, if you're too ill, can't swallow, or your stomach isn't absorbing medicines properly. As soon as you're...
  • Why am I getting doxycycline through an IV instead of just taking a pill?
  • It treats a wide range of serious bacterial infections — things like Rocky Mountain spotted fever, anthrax, plague, typhus, cholera, certain sexually transmitted infections, and re...
  • What infections does doxycycline injection actually treat?
📖 Read our full Doxycycline Injection guide →

🕸️ Concept Web — How Doxycycline hyclate 200 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Doxycycline hyclate 200 MG Injection RxCUI 1998483

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Doxycycline 3640
    • Doxycycline hyclate 23663
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Doxycycline Injection 1652652
    • Doxycycline hyclate Injection 2649326
    • Doxycycline Injectable Product 1160776
    • Doxycycline hyclate Injectable Product 2661232
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Doxycycline hyclate 200 MG 1652669

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Doxycycline hyclate 200 MG SCDC · 1652669
  • Doxycycline Injection SCDF · 1652652
  • Doxycycline hyclate Injection SCDFP · 2649326
  • Doxycycline Injectable Product SCDG · 1160776
  • Doxycycline hyclate Injectable Product SCDGP · 2661232

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1998483 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68382-0910-10 10 VIAL in 1 CARTON (68382-910-10) / 10 mL in 1 VIAL Doxycycline Zydus Pharmaceuticals USA Inc. 2018-02-01
68382-0911-01 1 VIAL in 1 CARTON (68382-911-01) / 20 mL in 1 VIAL Doxycycline Zydus Pharmaceuticals USA Inc. 2018-02-01
70771-1121-06 10 VIAL in 1 CARTON (70771-1121-6) / 10 mL in 1 VIAL (70771... Doxycycline Zydus Lifesciences Limited 2018-02-01
70771-1122-01 1 VIAL in 1 CARTON (70771-1122-1) / 20 mL in 1 VIAL Doxycycline Zydus Lifesciences Limited 2018-02-01
Observed labelers: Zydus Lifesciences Limited (2) · Zydus Pharmaceuticals USA Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1271 Inj doxycycline hyclate 1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.